April 8, 2013
The Biodesign® ENT Tissue Repair Graft, which was recently cleared by the United States Food and Drug Administration, minimizes the need to harvest autologous grafts in nasal/sinus cavity surgical procedures.
January 9, 2013
The audit found Cook Biotech to be in compliance, confirming again the certification for all Cook Biotech products that carry the CE Mark.
December 17, 2012
Cook’s next hernia/parastomal hands-on cadaver lab is slated for Feb. 21-22 in San Diego. Topics will include hiatal hernia repair, parastomal hernia repair and abdominal wall reconstruction.
Cook Medical to Host Workshop: “Parastomal Reinforcement & Abdominal Wall Reconstruction Using Component Separation”
May 8, 2012
Cook Medical will host an educational workshop, “Parastomal Reinforcement & Abdominal Wall Reconstruction Using Component Separation,” on May 17-18 in the Orlando, Fla., area.
April 20, 2012
Held March 29-30, 2012, at Florida Hospital’s Nicholson Center for Surgical Advancement in Celebration, Florida, the lab was conducted by the faculty of Robert M. Rogers Jr., MD; Carl Zimmerman, MD; and Lydia Watson, MD. The cadaver lab topics included “Anterior Repair and Support: Millimeter by Millimeter Dissection Technique” and “Posterior Repair and Support: Millimeter by Millimeter Dissection Technique.”
Cook Medical Supports the FDA's Evaluation of Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse, but Urges Further Analysis
September 7, 2011
Cook Medical supports the FDA's efforts to protect women's health and its review of the issues surrounding the use of surgical mesh for the treatment of pelvic floor disorders. We commend the FDA's support of open scientific discussion of the effectiveness of transvaginal surgical mesh placement for pelvic organ prolapse repair.
Dr. N. Joseph Espat Presented Positive Clinical Results on the Use of Biologics for Abdominal Wall Reconstruction in Chemotherapy Patients
June 29, 2009
Dr. N. Joseph Espat M.D., M.S., FACS presented favorable results of biologic materials, specifically Cook Medical’s Biodesign®, for the treatment of abdominal wall wounds complicated from chemotherapy, at the Abdominal Wall Reconstruction Conference at the Georgetown University Hospital in Washington, D.C. Dr. Espat is professor of surgery at Boston University School of Medicine, and chief of surgical oncology and vice-chair of surgery at Roger Williams Medical Center. At the conference, Dr. Espat presented “Pilot assessment of the role of biomaterials as adjuvant to abdominal wall closure subsequent to hyperthermic chemotherapy” and “The role of biomaterials as adjuvant to abdominal wall closure in chemotherapy exposed patients.”
March 23, 2009
The study, the largest published series with the longest follow-up time for a biologic mesh used in hernia repair, demonstrated that the Biodesign Hernia Graft possesses the clinically important strength of non-absorbable mesh, while providing the benefit of decreased infection complications of absorbable mesh.
Cook Medical Reports Positive Results from Clinical Trial Designed to Evaluate Safety and Efficacy of Biodesign® Vaginal Erosion Repair Graft
March 10, 2009
An 11-month clinical study led by Manish P. Patel, M.D., generated positive results on Cook Medical’s Biodesign® Vaginal Erosion Repair Graft for the treatment of vaginal mesh exposures, a common complication resulting from the use of synthetic mesh in pelvic floor repair, the procedure used to treat pelvic organ prolapse. The results, which confirmed the safety and efficacy of Biodesign, were presented at the 2009 Society for Urodynamics and Female Urology Winter Meeting in Las Vegas.
January 16, 2009
Dr. France A. Córdova, president of Purdue University, praised Cook Medical for its continued support and partnership on Wednesday at Cook’s world headquarters in Bloomington.
Córdova, an internationally recognized astrophysicist, emphasized the importance of industry and academic partnerships, like the Indiana Innovation Alliance (IIA), to continue growth in the biosciences arena. Despite recent government cutbacks, IIA strives to make Indiana a hotspot for life sciences and biosciences research by partnering with health and life sciences organizations, Indiana University, Purdue University and the state government.